DJ Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slid 1.77% to $61.15 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.75% to 7,706.03 and Dow Jones Industrial Average falling 0.68% to 51,511.59.
This was the stock's third consecutive day of losses.
Bristol Myers Squibb Co. closed 10.91% short of its 52-week high of $68.64, which the company reached on August 19th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.01% to $269.17, Pfizer Inc. $(PFE)$ rose 0.90% to $28.18, and Abbott Laboratories $(ABT)$ fell 0.19% to $103.49.
Trading volume (14.4 M) eclipsed its 50-day average volume of 10.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.